
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $292.7M | $390.1M | $473.6M | $499.2M | $551M | |
Revenue Growth (YoY) | 15.15% | 33.29% | 21.4% | 5.39% | 10.38% | |
Cost of Revenues | $44.3M | $59.4M | $69.8M | $71.8M | $93.8M | |
Gross Profit | $248.4M | $330.7M | $403.8M | $427.4M | $457.1M | |
Gross Profit Margin | 84.88% | 84.78% | 85.26% | 85.63% | 82.97% | |
R&D Expenses | $99.4M | $137.9M | $177.9M | $183.8M | $196.8M | |
Selling, General & Admin | $227.5M | $291.5M | $347.1M | $360.8M | $378M | |
Other Inc / (Exp) | -$1.7M | -$1.7M | $5.5M | $10.3M | $11.9M | |
Operating Expenses | $326.8M | $429.4M | $525M | $544.6M | $574.8M | |
Operating Income | -$78.4M | -$98.7M | -$121.2M | -$117.2M | -$117.7M | |
Net Interest Expenses | $5.8M | $10.4M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$85.9M | -$110.8M | -$110.8M | -$86.9M | -$83M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $8.1M | $6M | $13.7M | $14M | $12.8M | |
Net Income to Company | -$94M | -$116.9M | -$124.5M | -$100.9M | -$95.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$94M | -$116.9M | -$124.5M | -$100.9M | -$95.8M | |
Basic EPS (Cont. Ops) | -$1.00 | -$1.11 | -$1.14 | -$0.92 | -$0.86 | |
Diluted EPS (Cont. Ops) | -$1.00 | -$1.11 | -$1.14 | -$0.92 | -$0.86 | |
Weighted Average Basic Share | $94.3M | $105.3M | $109.3M | $109.1M | $111.7M | |
Weighted Average Diluted Share | $94.3M | $105.3M | $109.3M | $109.1M | $111.7M | |
EBITDA | -$69.6M | -$96.8M | -$95.5M | -$72M | -$67.3M | |
EBIT | -$79.8M | -$107.7M | -$107.6M | -$83.7M | -$78.4M | |
Revenue (Reported) | $292.7M | $390.1M | $473.6M | $499.2M | $551M | |
Operating Income (Reported) | -$78.4M | -$98.7M | -$121.2M | -$117.2M | -$117.7M | |
Operating Income (Adjusted) | -$79.8M | -$107.7M | -$107.6M | -$83.7M | -$78.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $74.8M | $96.3M | $107.3M | $114M | $136.4M | |
Revenue Growth (YoY) | 38.04% | 28.72% | 11.5% | 6.23% | 19.65% | |
Cost of Revenues | $13.5M | $17.8M | $17.6M | $21.3M | $29M | |
Gross Profit | $61.3M | $78.5M | $89.7M | $92.7M | $107.4M | |
Gross Profit Margin | 81.97% | 81.5% | 83.57% | 81.28% | 78.73% | |
R&D Expenses | $30.1M | $43.6M | $44.7M | $47.8M | $54.2M | |
Selling, General & Admin | $65.3M | $83M | $88.1M | $92.5M | $97M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $95.4M | $126.5M | $132.8M | $140.3M | $151.2M | |
Operating Income | -$34.1M | -$48.1M | -$43.1M | -$47.6M | -$43.8M | |
Net Interest Expenses | $1M | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$35.1M | -$47.3M | -$35.3M | -$39.1M | -$31.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $559K | $1.4M | $3M | $1.4M | $4M | |
Net Income to Company | -$35.7M | -$48.8M | -$38.3M | -$40.5M | -$35.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$35.7M | -$48.8M | -$38.3M | -$40.5M | -$35.8M | |
Basic EPS (Cont. Ops) | -$0.36 | -$0.45 | -$0.35 | -$0.37 | -$0.32 | |
Diluted EPS (Cont. Ops) | -$0.36 | -$0.45 | -$0.35 | -$0.37 | -$0.32 | |
Weighted Average Basic Share | $100.2M | $108.2M | $108.4M | $110M | $112.7M | |
Weighted Average Diluted Share | $100.2M | $108.2M | $108.4M | $110M | $112.7M | |
EBITDA | -$31.7M | -$45.4M | -$40.2M | -$44.7M | -$41.3M | |
EBIT | -$34.1M | -$48.1M | -$43.1M | -$47.6M | -$43.8M | |
Revenue (Reported) | $74.8M | $96.3M | $107.3M | $114M | $136.4M | |
Operating Income (Reported) | -$34.1M | -$48.1M | -$43.1M | -$47.6M | -$43.8M | |
Operating Income (Adjusted) | -$34.1M | -$48.1M | -$43.1M | -$47.6M | -$43.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $313.3M | $411.6M | $484.7M | $505.8M | $573.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $47.6M | $63.7M | $69.7M | $75.5M | $101.5M | |
Gross Profit | $265.7M | $347.9M | $415M | $430.4M | $471.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $106.7M | $151.4M | $179M | $186.9M | $203.1M | |
Selling, General & Admin | $238.8M | $309.2M | $352.3M | $365.2M | $382.5M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $345.6M | $460.6M | $531.3M | $552.1M | $585.6M | |
Operating Income | -$79.8M | -$112.7M | -$116.3M | -$121.7M | -$113.8M | |
Net Interest Expenses | $8.2M | $8.7M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$89.8M | -$123.1M | -$98.8M | -$90.7M | -$75.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $8.5M | $6.9M | $15.3M | $12.4M | $15.3M | |
Net Income to Company | -$98.2M | -$130M | -$114.1M | -$103.1M | -$91.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$98.2M | -$130M | -$114.1M | -$103.1M | -$91.1M | |
Basic EPS (Cont. Ops) | -$1.02 | -$1.21 | -$1.04 | -$0.94 | -$0.81 | |
Diluted EPS (Cont. Ops) | -$1.02 | -$1.21 | -$1.04 | -$0.94 | -$0.81 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$74.9M | -$110.5M | -$90.3M | -$76.5M | -$63.9M | |
EBIT | -$85.3M | -$121.7M | -$102.7M | -$88.2M | -$74.6M | |
Revenue (Reported) | $313.3M | $411.6M | $484.7M | $505.8M | $573.4M | |
Operating Income (Reported) | -$79.8M | -$112.7M | -$116.3M | -$121.7M | -$113.8M | |
Operating Income (Adjusted) | -$85.3M | -$121.7M | -$102.7M | -$88.2M | -$74.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $74.8M | $96.3M | $107.3M | $114M | $136.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $13.5M | $17.8M | $17.6M | $21.3M | $29M | |
Gross Profit | $61.3M | $78.5M | $89.7M | $92.7M | $107.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $30.1M | $43.6M | $44.7M | $47.8M | $54.2M | |
Selling, General & Admin | $65.3M | $83M | $88.1M | $92.5M | $97M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $95.4M | $126.5M | $132.8M | $140.3M | $151.2M | |
Operating Income | -$34.1M | -$48.1M | -$43.1M | -$47.6M | -$43.8M | |
Net Interest Expenses | $1M | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$35.1M | -$47.3M | -$35.3M | -$39.1M | -$31.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $559K | $1.4M | $3M | $1.4M | $4M | |
Net Income to Company | -$35.7M | -$48.8M | -$38.3M | -$40.5M | -$35.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$35.7M | -$48.8M | -$38.3M | -$40.5M | -$35.8M | |
Basic EPS (Cont. Ops) | -$0.36 | -$0.45 | -$0.35 | -$0.37 | -$0.32 | |
Diluted EPS (Cont. Ops) | -$0.36 | -$0.45 | -$0.35 | -$0.37 | -$0.32 | |
Weighted Average Basic Share | $100.2M | $108.2M | $108.4M | $110M | $112.7M | |
Weighted Average Diluted Share | $100.2M | $108.2M | $108.4M | $110M | $112.7M | |
EBITDA | -$31.7M | -$45.4M | -$40.2M | -$44.7M | -$41.3M | |
EBIT | -$34.1M | -$48.1M | -$43.1M | -$47.6M | -$43.8M | |
Revenue (Reported) | $74.8M | $96.3M | $107.3M | $114M | $136.4M | |
Operating Income (Reported) | -$34.1M | -$48.1M | -$43.1M | -$47.6M | -$43.8M | |
Operating Income (Adjusted) | -$34.1M | -$48.1M | -$43.1M | -$47.6M | -$43.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $234.1M | $805.8M | $367.8M | $230.7M | $185.6M | |
Short Term Investments | $64.2M | $1.9M | $364.7M | $303M | $382.8M | |
Accounts Receivable, Net | $94.2M | $117.2M | $136M | $169.1M | $192.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $8.3M | $7.1M | $10.6M | $23.8M | $30.8M | |
Other Current Assets | -- | -- | -- | -- | $116.8M | |
Total Current Assets | $419.8M | $959.2M | $905.7M | $767.2M | $878.1M | |
Property Plant And Equipment | $85.1M | $102M | $95.8M | $85.8M | $76.4M | |
Long-Term Investments | -- | -- | -- | $211.1M | $658.9M | |
Goodwill | $23.1M | $23.1M | $23.1M | $23.1M | $23.1M | |
Other Intangibles | $5.8M | $4.3M | $2.8M | $1.3M | -- | |
Other Long-Term Assets | $21.6M | $19.8M | $16.3M | $15.5M | $27.8M | |
Total Assets | $555.5M | $1.1B | $1B | $1.1B | $1.7B | |
Accounts Payable | $850K | $5.3M | $3M | $672K | $4.3M | |
Accrued Expenses | $45.9M | $63.7M | $63.2M | $74.5M | $91.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $250.5M | |
Current Portion Of Capital Lease Obligations | -- | $8.8M | $9.9M | $10M | $10.8M | |
Other Current Liabilities | $37.3M | $29.8M | $42.2M | $40.5M | $62.8M | |
Total Current Liabilities | $182.6M | $211.8M | $228.7M | $306.8M | $709.9M | |
Long-Term Debt | $218.5M | $225.3M | $249M | $250.5M | $450.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $461.4M | $511.9M | $541.6M | $614.3M | $1.2B | |
Common Stock | $95K | $108K | $108K | $109K | $113K | |
Other Common Equity Adj | $9.4M | $6.1M | -$9.6M | -$8.6M | $2.7M | |
Common Equity | $94.1M | $596.6M | $502.1M | $489.6M | $455.7M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $94.1M | $596.6M | $502.1M | $489.6M | $455.7M | |
Total Liabilities and Equity | $555.5M | $1.1B | $1B | $1.1B | $1.7B | |
Cash and Short Terms | $298.3M | $807.6M | $732.5M | $533.7M | $568.4M | |
Total Debt | $218.5M | $225.3M | $249M | $250.5M | $700.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $753.6M | $775.7M | $248.6M | $147.1M | $153.1M | |
Short Term Investments | $70.4M | $28.4M | $507.7M | $401M | $456.1M | |
Accounts Receivable, Net | $51.3M | $63.6M | $75.4M | $100.4M | $123.6M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $24.6M | $35.8M | $44.4M | $59.2M | $85.3M | |
Total Current Assets | $899.8M | $903.5M | $876M | $707.8M | $818.1M | |
Property Plant And Equipment | $89.9M | $100.8M | $93.3M | $81M | $74.6M | |
Long-Term Investments | -- | -- | -- | $226.4M | $591.7M | |
Goodwill | $23.1M | $23.1M | $23.1M | $23.1M | $39.8M | |
Other Intangibles | $5.5M | $3.9M | $2.4M | $881K | $6M | |
Other Long-Term Assets | $19.4M | $20.1M | $16.4M | $14.6M | $46.9M | |
Total Assets | $1B | $1.1B | $1B | $1.1B | $1.6B | |
Accounts Payable | $637K | $4.8M | $708K | $2.9M | $6.3M | |
Accrued Expenses | $87M | $92.6M | $107.3M | $109.2M | $156.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $250.9M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $179.3M | $196.1M | $217.3M | $297.2M | $710.1M | |
Long-Term Debt | $220.1M | $247.8M | $249.3M | $250.9M | $450.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $459.2M | $515.8M | $530M | $601.3M | $1.2B | |
Common Stock | $106K | $110K | $110K | $112K | $113K | |
Other Common Equity Adj | $4.2M | $2.9M | -$14.4M | -$9.1M | -$1.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $578.6M | $535.8M | $481.3M | $452.3M | $367.7M | |
Total Liabilities and Equity | $1B | $1.1B | $1B | $1.1B | $1.6B | |
Cash and Short Terms | $824M | $804.1M | $756.3M | $548.1M | $609.2M | |
Total Debt | $220.1M | $247.8M | $249.3M | $250.9M | $701.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$94M | -$116.9M | -$124.5M | -$100.9M | -$95.8M | |
Depreciation & Amoritzation | $10.2M | $10.9M | $12.2M | $11.7M | $11.1M | |
Stock-Based Compensation | $68.6M | $109.8M | $142.9M | $139.8M | $126.7M | |
Change in Accounts Receivable | -$19.1M | -$23M | -$18.8M | -$33.1M | -$23.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$5.8M | $7.2M | $11.9M | $59.4M | $115.2M | |
Capital Expenditures | $10.1M | $10.5M | $11.4M | $5.1M | $13.3M | |
Cash Acquisitions | -$29.4M | -- | -- | -- | -- | |
Cash From Investing | -$54.7M | $54.4M | -$374.3M | -$143.1M | -$532.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $245.3M | -- | -- | -- | $449.6M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -$56.4M | -$43.5M | -- | |
Other Financing Activities | -$29.3M | -$1M | -$31.1M | -$21.4M | -$93.8M | |
Cash From Financing | $225.8M | $510.1M | -$75.6M | -$53.4M | $371.9M | |
Beginning Cash (CF) | $68.9M | $234.1M | $805.8M | $367.8M | $230.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $165.2M | $571.7M | -$438M | -$137.1M | -$45.2M | |
Ending Cash (CF) | $234.1M | $805.8M | $367.8M | $230.7M | $185.6M | |
Levered Free Cash Flow | -$16M | -$3.3M | $475K | $54.3M | $101.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$35.7M | -$48.8M | -$38.3M | -$40.5M | -$35.8M | |
Depreciation & Amoritzation | $2.3M | $2.7M | $2.9M | $2.9M | $2.4M | |
Stock-Based Compensation | $21.4M | $36M | $35.8M | $32.1M | $32.3M | |
Change in Accounts Receivable | $42.9M | $53.6M | $60.6M | $68.7M | $65.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $20.4M | $24.5M | $36.8M | $56.7M | $68M | |
Capital Expenditures | $1.1M | $3.5M | $1.1M | $297K | $2.7M | |
Cash Acquisitions | -- | -- | -- | -- | -$18.6M | |
Cash From Investing | -$4.8M | -$31.9M | -$142.5M | -$112M | -$25M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -$2.5M | -- | -$61.3M | |
Other Financing Activities | -$731K | -$28.8M | -$16.9M | -$34.9M | -$21.4M | |
Cash From Financing | $504M | -$22.7M | -$13.5M | -$28.4M | -$75.5M | |
Beginning Cash (CF) | $234.1M | $805.8M | $367.8M | $230.7M | $185.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $519.5M | -$30M | -$119.2M | -$83.7M | -$32.5M | |
Ending Cash (CF) | $753.6M | $775.7M | $248.6M | $147.1M | $153.1M | |
Levered Free Cash Flow | $19.3M | $21M | $35.7M | $56.4M | $65.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$98.2M | -$130M | -$114.1M | -$103.1M | -$91.1M | |
Depreciation & Amoritzation | $10.4M | $11.2M | $12.4M | $11.7M | $10.6M | |
Stock-Based Compensation | $77.1M | $124.4M | $142.7M | $136.1M | $126.8M | |
Change in Accounts Receivable | -$12.9M | -$12.3M | -$11.8M | -$25M | -$27.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $10.7M | $11.3M | $24.2M | $79.3M | $126.5M | |
Capital Expenditures | $8.6M | $12.9M | $9M | $4.3M | $15.7M | |
Cash Acquisitions | -- | -- | -- | -- | -$18.6M | |
Cash From Investing | -$60M | $27.4M | -$484.9M | -$112.5M | -$445.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -$59M | -$41M | -$61.3M | |
Other Financing Activities | -$30.1M | -$29.1M | -$19.1M | -$39.4M | -$80.3M | |
Cash From Financing | $725.4M | -$16.6M | -$66.4M | -$68.3M | $324.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $676.1M | $22.1M | -$527.1M | -$101.5M | $6.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $2M | -$1.5M | $15.1M | $75M | $110.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$35.7M | -$48.8M | -$38.3M | -$40.5M | -$35.8M | |
Depreciation & Amoritzation | $2.3M | $2.7M | $2.9M | $2.9M | $2.4M | |
Stock-Based Compensation | $21.4M | $36M | $35.8M | $32.1M | $32.3M | |
Change in Accounts Receivable | $42.9M | $53.6M | $60.6M | $68.7M | $65.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $20.4M | $24.5M | $36.8M | $56.7M | $68M | |
Capital Expenditures | $1.1M | $3.5M | $1.1M | $297K | $2.7M | |
Cash Acquisitions | -- | -- | -- | -- | -$18.6M | |
Cash From Investing | -$4.8M | -$31.9M | -$142.5M | -$112M | -$25M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -$2.5M | -- | -$61.3M | |
Other Financing Activities | -$731K | -$28.8M | -$16.9M | -$34.9M | -$21.4M | |
Cash From Financing | $504M | -$22.7M | -$13.5M | -$28.4M | -$75.5M | |
Beginning Cash (CF) | $234.1M | $805.8M | $367.8M | $230.7M | $185.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $519.5M | -$30M | -$119.2M | -$83.7M | -$32.5M | |
Ending Cash (CF) | $753.6M | $775.7M | $248.6M | $147.1M | $153.1M | |
Levered Free Cash Flow | $19.3M | $21M | $35.7M | $56.4M | $65.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.